Improving Pregnancy Outcomes With Progesterone
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to HIV-1-infection
Related studies linked through entity extraction aliases.
Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression
- Status
- COMPLETED
- Phase
- NA
Dolutegravir in Pregnant HIV Mothers and Their Neonates
- Status
- COMPLETED
- Phase
- PHASE3
Mental Ability Challenge Study in Adults With and Without HIV
- Status
- COMPLETED
- Phase
- N/A
A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings
- Status
- COMPLETED
- Phase
- PHASE1
Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV
- Status
- COMPLETED
- Phase
- NA
A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers
- Status
- UNKNOWN
- Phase
- PHASE1
A Retrospective Study to Evaluate the Safety and Efficacy of a Nucleoside-Sparing Regimen of Darunavir, Ritonavir, and Dolutegravir
- Status
- COMPLETED
- Phase
- N/A
Providing Unique Support for Health (PUSH) Study
- Status
- COMPLETED
- Phase
- NA
Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected
- Status
- UNKNOWN
- Phase
- N/A
Pharmacokinetics Distribution of Raltegravir by PET/MR
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances
- Status
- UNKNOWN
- Phase
- NA
Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)
- Status
- COMPLETED
- Phase
- PHASE4
Primary Infection Cohort
- Status
- UNKNOWN
- Phase
- N/A
Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE1
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed
- Status
- COMPLETED
- Phase
- PHASE3
INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV
- Status
- TERMINATED
- Phase
- NA
Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria
- Status
- COMPLETED
- Phase
- PHASE4